Table 1: Literature review of pediatric N. fowleri cases treated with hypothermia.
Author |
Patient Age (yrs)/Sex |
Pharmaceutical Management |
Administered Treatment |
Outcome |
Cope, et al., 2016 [10] |
12/M |
amphotericin B, azithromycin, dexamethasone, fluconazole, miltefosine, rifampin |
Surgical decompression, hypertonic saline and mannitol, induced hypothermia (no description) |
Brain death |
Linam, et al., 2015 [7]; Dunn, et al., 2016 [8]; Heggie, et al., 2017 [9] |
12/F |
amphotericin B, azithromycin, dexamethasone, fluconazole, hyperosmolar therapy, miltefosine, rifampin |
External ventricular drain, CSF drainage, moderate hyperventilation, induced hypothermia (32-34 °C) in the management of PAM |
Full neurologic recovery; cerebral edema resolved after using hypothermia in conjunction with other therapies |
Stowe, et al., 2017 [11] |
14/M |
amphotericin B, azithromycin, ceftriaxone, fluconazole, miltefosine, pentobarbital, rifampin, vancomycin |
Induced hypothermia (no description) |
Death |
PAM: Primary amebic meningoencephalitis; CSF: Cerebral spinal fluid